RYDAPT

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug RYDAPT contains one active pharmaceutical ingredient (API):

1 Midostaurin
UNII ID912S5VON - MIDOSTAURIN

Midostaurin inhibits multiple receptor tyrosine kinases, including FLT3 and KIT kinase. Midostaurin inhibits FLT3 receptor signalling and induces cell cycle arrest and apoptosis in leukaemic cells expressing FLT3 ITD or TKD mutant receptors or over-expressing FLT3 wild type receptors.

Read about Midostaurin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RYDAPT Soft capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01EX10 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11505M, 11506N, 11518F, 11531X, 11552B, 11553C
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 526518080094101
Country: EE Ravimiamet Identifier(s): 1753769, 1764794
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1171218001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 500476, 519755
Country: FR Base de données publique des médicaments Identifier(s): 67868413
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 353634
Country: HK Department of Health Drug Office Identifier(s): 65725
Country: IE Health Products Regulatory Authority Identifier(s): 89103
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8106, 8107
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1083947, 1084937
Country: NL Z-Index G-Standaard, PRK Identifier(s): 148016
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 20639
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100392385
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64447001
Country: SG Health Sciences Authority Identifier(s): 15518P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699504190151
Country: US FDA, National Drug Code Identifier(s): 0078-0698

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.